MedPath

Effect of meditation on hemodialysis adequacy and some psychological symptoms

Phase 2
Conditions
Condition 1: Anxiety. Condition 2: Depression. Condition 3: Stress.
Anxiety disorder, unspecified
Depressive episode, unspecified
Stress, not elsewhere classified
Registration Number
IRCT2014102917454N3
Lead Sponsor
Vice chancellor for research, Zanjan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
67
Inclusion Criteria

The inclusion criteria: diagnosed with chronic kidney disease by their physicians; being under hemodialysis for at least three months; not having participated in other intervention studies; ability to participate in training sessions; ability to do meditation exercises; being registered in the hospital; lack of previous experiences with meditation; and lack of specific medical prohibitions, such as deafness, blindness, end-stage heart failure, brain trauma, uncontrolled hypertension and acute glaucoma; being consent to participate in the study; Lack of psychological drug use; lack of proved psychological disease. The exclusion criteria include unable or unwilling to participate in a group program; having reduced cognitive ability; hospitalized because of other medical conditions; having contraindications for doing meditation exercises; kidney transplantation during the study or referring to other hospitals; fistula or graft damages; and using psychological medications during the study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anxiety. Timepoint: Before the intervention, four weeks after the intervention and after 8 weeks of intervention. Method of measurement: Depression, Anxiety, Stress Scale- 21 (DASS-21).;Depression. Timepoint: Before the intervention, four weeks after the intervention and after 8 weeks of intervention. Method of measurement: Depression, Anxiety, Stress Scale- 21 (DASS-21).;Stress. Timepoint: Before the intervention, four weeks after the intervention and after 8 weeks of intervention. Method of measurement: Depression, Anxiety, Stress Scale- 21 (DASS-21).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath